News

CENTENE TO PRESENT AT BERNSTEIN 39TH ANNUAL STRATEGIC DECISIONS CONFERENCE

Published

4 seconds ago

May 13, 2023

ST. LOUIS, May 12, 2023 /PRNewswire/ — Centene Corporation (NYSE: CNC) announced today it will present at the Bernstein 39th Annual Strategic Decisions Conference, to be held Wednesday, May 31-Friday, June 2, 2023, in New York City.

Centene will present on Thursday, June 1^st at 9:00 a.m. Eastern Time (ET). A simultaneous live audio webcast is available at: https://kvgo.com/bernstein-2023-39th-annual-sdc/centene-corp-june.

A webcast replay will be available afterwards via the Company’s website at www.centene.com, under the Investors section.

About Centene Corporation
Centene Corporation, a Fortune 500 company, is a leading healthcare enterprise that is committed to helping people live healthier lives. The Company takes a local approach – with local brands and local teams – to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. Centene offers affordable and high-quality products to nearly 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace, the TRICARE program. The Company also contracts with other healthcare and commercial organizations to provide a variety of specialty services focused on treating the whole person. Centene focuses on long-term growth and value creation as well as the development of its people, systems and capabilities so that it can better serve its members, providers, local communities, and government partners.

Centene uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Centene is routinely posted and is accessible on Centene’s investor relations website, http://investors.centene.com.

SOURCE Centene Corporation